Status:

RECRUITING

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Lead Sponsor:

Hoffmann-La Roche

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

40-90 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have completed the 52-week ...

Eligibility Criteria

Inclusion

  • Completion of the 52-week treatment period in either parent GB43311 or GB44332

Exclusion

  • Withdrawal of consent and/or premature discontinuation from parent study
  • Any permanent discontinuation of study drug in parent study
  • Significant non-compliance in the parent study, specifically defined as missing scheduled visits, per investigator's judgment
  • Any new diagnosis of asthma according to the Global Initiative for Asthma guidelines or other accepted guidelines since enrolling in the parent study
  • Any new clinically significant pulmonary disease other than COPD (e.g., pulmonary fibrosis, sarcoidosis, chronic pulmonary embolism or primary pulmonary hypertension, alpha-1-antitrypsin deficiency) since enrolling in the parent study
  • Any new unstable cardiac disease, myocardial infarction, or New York Heart Association Class III or IV heart failure since enrolling in the parent study

Key Trial Info

Start Date :

June 28 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2027

Estimated Enrollment :

2000 Patients enrolled

Trial Details

Trial ID

NCT05878769

Start Date

June 28 2023

End Date

June 30 2027

Last Update

March 3 2026

Active Locations (482)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 121 (482 locations)

1

UAB Lung Health Center

Birmingham, Alabama, United States, 35205-2610

2

SEC Clinical Research LLC - Dothan 2 - ClinEdge - PPDS

Dothan, Alabama, United States, 36305

3

Jasper Summit Research LLC

Jasper, Alabama, United States, 35501

4

Pulmonary Associates of Mobile PC

Mobile, Alabama, United States, 36608-3135